FDA Adverse Event Injury Summary report: N

GE SIGNA EXCITE 3.0T MR SYSTEM

MDR report key: 23198925 · Received October 2, 2025

Report

Report Number
2183553-2025-00017
Event Type
Injury
Date Received
October 2, 2025
Date of Event
August 1, 2025
Report Date
November 14, 2025
Manufacturer
GE MEDICAL SYSTEMS, LLC
Product Code
LNH
PMA / PMN Number
K041476
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 0

B4; G1, 3, 6; H2, 3, 6. H3: GE HEALTHCARE (GEHC) INVESTIGATION HAS BEEN COMPLETED. AN ACOUSTIC PERFORMANCE TEST WAS PERFORMED PER NEMA STANDARDS PUBLICATION NO. MS4-2010 (ACOUSTIC NOISE MEASUREMENT PROCEDURE FOR DIAGNOSTIC MAGNETIC RESONANCE IMAGING DEVICES) AND IEC/CEI 60601-2-33 CLAUSE 26. THE TESTING CONCLUDED THAT THE SYSTEM WAS WITHIN THE SPECIFICATION FOR THIS SYSTEM CONFIGURATION. THE INCIDENT APPEARS TO BE THE RESULT OF HUMAN MEDICAL CONDITION(S). THE PATIENT WAS PROVIDED PROPER HEARING PROTECTION DURING THE SCAN. HUMAN CONDITIONS MAY CAUSE SENSITIVITY TO ACOUSTIC LEVELS THAT OCCUR DURING NORMAL CLINICAL SCANNING. NO SYSTEM ISSUE WAS FOUND. NO CORRECTIONS ARE REQUIRED AS THE SYSTEM WAS OPERATING WITHIN SPECIFICATION.

Additional Manufacturer Narrative · 0

LEGAL MANUFACTURER: HCS MR - 3200 N GRANDVIEW BLVD. USA WAUKESHA, WI 53188. D: THERE ARE NO ADDITIONAL DEVICE IDENTIFICATION NUMBERS. D4: PRIMARY UDI NUMBER: THERE IS NO UDI AVAILABLE AS THE DEVICE WAS MANUFACTURED PRIOR TO UDI COMPLIANCE REQUIREMENTS. H3, 6: GE HEALTHCARE'S INVESTIGATION IS ONGOING. A FOLLOW UP REPORT WILL BE SUBMITTED ONCE THE INVESTIGATION HAS BEEN COMPLETED.

Description of Event or Problem · 0

A PATIENT WHO UNDERWENT AN MRI OF THE ORBITS REPORTED TO HAVE SUSTAINED BILATERAL HEARING LOSS AND NERVE DAMAGE AS DETERMINED BY AN AUDIOLOGIST ON (B)(6) 2025.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2623357 GE SIGNA EXCITE 3.0T MR SYSTEM NUCLEAR MAGNETIC RESONANCE IMAGING LNH GE MEDICAL SYSTEMS, LLC

Patients

Seq Age Sex Outcome Treatment
1 75 YR Female Other